Clinical Trial Update: Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Ferrisat to placebo for anemia in inflammatory bowel disease during anti-TNF therapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Inflammatory Bowel Disease

Drugs mentioned

• Ferrisat

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Inflammatory Bowel Disease | Phase 3 | Status: TERMINATED